Contents

Current Radiopharmaceuticals, Volume 6 - Number 2

Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer

, 6(2): 57 - 71

Sean L. Kitson, Vincenzo Cuccurullo, Thomas S. Moody and Luigi Mansi


DOI: 10.2174/1874471011306020001




Generator Breakthrough and Radionuclidic Purification in Automated Synthesis of 68Ga-DOTANOC

, 6(2): 72 - 77

Francesca Belosi, Gianfranco Cicoria, Filippo Lodi, Claudio Malizia, Stefano Fanti, Stefano Boschi and Mario Marengo


DOI: 10.2174/1874471011306020002




Comparing High LET 227Th- and Low LET 177Lu-trastuzumab in Mice with HER-2 Positive SKBR-3 Xenografts

, 6(2): 78 - 86

Nasir Abbas, Helen Heyerdahl, Oyvind S. Bruland, Ellen Mengshoel Brevik and Jostein Dahle


DOI: 10.2174/18744710113069990017




[131I]IAZA as a Molecular Radiotherapeutic (MRT) Drug: Wash-Out with Cold IAZA Accelerates Clearance in a Murine Tumor Model

, 6(2): 87 - 91

John R. Mercer, Alexander J.B. McEwan and Leonard I. Wiebe


DOI: 10.2174/1874471011306020004




The Dilemma of Localizing Disease Relapse After Radical Treatment for Prostate Cancer: Which is the Value of the Actual Imaging Techniques?

, 6(2): 92 - 95

Schiavina R, Ceci F, Borghesi M, Brunocilla E, Vagnoni V, Gacci M, Castellucci P, Nanni C, Martorana G and Fanti S


DOI: 10.2174/1874471011306020005




What is Currently the Best Radiopharmaceutical for the Hybrid PET/CT Detection of Recurrent Medullary Thyroid Carcinoma?

, 6(2): 96 - 105

Slavikova K, Montravers F, Treglia G, Kunikowska J., Kaliska L, Vereb M, Talbot JN and Balogova S


DOI: 10.2174/1874471011306020006




Targeted Alpha Therapy with 227Th-trastuzumab of Intraperitoneal Ovarian Cancer in Nude Mice

, 6(2): 106 - 116

Helen Heyerdahl, Nasir Abbas, Kristine Sponheim, Camilla Mollatt, Oyvind Bruland and Jostein Dahle


DOI: 10.2174/18744710113069990018




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science